NCT05376527 2026-04-21Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact"Oncostar" LLCPhase 1 Completed34 enrolled 18 charts
NCT01443260 2025-04-30A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal CarcinomatosisGenelux CorporationPhase 1/2 Completed9 enrolled